Open AccessChange of circulating antibodies against CD25-derived peptide antigen in hepatocellular carcinoma
Author(s) -
Jiaxin Wang,
Yangchun Xu,
Huan Zhao,
Xuan Zhang
Publication year - 2017
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/jcrt.jcrt_823_17
Subject(s) - hepatocellular carcinoma , antibody , medicine , il 2 receptor , antigen , malignancy , gastroenterology , receiver operating characteristic , endocrinology , immunology , immune system , t cell
Several studies have shown altered levels of plasma anti-CD25 antibodies in patients with malignancy in lung, esophagus and breast. The present study was thus designed to test whether circulating anti-CD25 antibody levels were changed in hepatocellular carcinoma (HCC).